F. prausnitzii ferments dietary fiber to butyrate and other short-chain fatty acids. It is anaerobic and often under-detected if samples are not handled properly. Many tests report it at species level; some assays group it within broader clostridial clusters.

Why Faecalibacterium prausnitzii appears on health-focused microbiome tests

F. prausnitzii is a Gram-positive, anaerobic, butyrate-producing bacterium belonging to Clostridium cluster IV. It is often one of the most abundant species in healthy adult colons and is widely used as a positive health-associated marker on commercial reports.

Its appeal as a marker is straightforward: butyrate supports colonic epithelial energy metabolism, and multiple studies link lower F. prausnitzii abundance to intestinal inflammation, especially in Crohn’s disease research.

What higher or lower abundance might mean (association only)

PatternResearch associationsWhat it is not
Lower relative abundanceReported in active IBD, after some antibiotics, and with low-fiber diets in various cohortsA diagnosis of IBD or “leaky gut”
Higher relative abundanceCommon in healthy controls and fiber-rich dietary contexts in observational dataProof of protection from future disease

Because F. prausnitzii is strictly anaerobic, technical factors (sample delay, aerobic exposure, extraction method) can artificially lower detected abundance.

Depletion pattern in IBD meta-analyses

F. prausnitzii belongs to Ruminococcaceae (Clostridiales). Cross-study re-analysis (Duvallet et al., 2017) found IBD patient microbiomes were dominated by depletion of health-associated genera relative to controls, especially butyrate-producing Ruminococcaceae and Lachnospiraceae, with five genera from those families consistently depleted in IBD patients in at least two of four IBD studies. That pattern fits the “missing health-associated bacteria” dysbiosis model more than enrichment of a single pathogen.

Important limit from the same paper: no individual microbe was consistently associated with IBD across all studies, even when overall community differences were common. Low F. prausnitzii on a consumer report is consistent with IBD-associated depletion literature but does not diagnose IBD, calprotectin, symptoms, and endoscopy drive care. Low abundance also overlaps diarrhoea, antibiotics, and general sickness signatures that deplete Clostridiales across diseases.

Chemical and functional role

  • Primary fermentation product: butyrate (short-chain fatty acid)
  • Substrates: dietary fiber, resistant starch, other polysaccharides reaching the colon
  • Host relevance: butyrate is a preferred energy source for colonocytes; anti-inflammatory mechanisms studied in vitro and in animal models

On your microbiome report

  • Reported as percent of community or a qualitative band (low / normal / high)
  • Compare trends only with same lab and method
  • Interpret alongside diet, medications, inflammation markers, and symptoms, not in isolation

Related: Alpha diversity, High-fiber diet, Gut motility (transit affects fermentation time).


What studies report

Individual scientific claims about this species, one per row. Each entry stands on its own, no synthesis required. Weak and emerging findings sit alongside stronger ones, so the full picture accumulates without waiting for a formal review.

DateSourceClaimTypeConfidenceNotes
2008Sokol et al., PNASF. prausnitzii and its supernatant associated with anti-inflammatory effects; reduced abundance in Crohn’s disease ileal mucosaassociationmedMechanistic and cohort data; not a diagnostic threshold for individuals
2013Miquel et al., ISME JLow fecal F. prausnitzii associated with higher risk of recurrent Crohn’s disease post-surgery in a cohortassociationmedObservational; confounded by diet and inflammation
ongoingConsumer microbiome reports“Low F. prausnitzii” alone indicates IBD or requires specific supplementationhypothesislowNot supported for individual clinical decisions

Reported associations

Observed associations between abundance shifts and health markers or biological outcomes. Direction and study context matter more than any single reading on a test report.

SpeciesDirectionOutcomeContextEvidence strengthSource
F. prausnitziiInflammatory bowel disease activity / recurrenceHuman cohort and mucosal studiesmoderateSokol et al., 2008; Miquel et al., 2013
F. prausnitziiButyrate production (colonic)Fiber-rich diets in intervention and observational studiesmoderateMultiple dietary fiber studies
F. prausnitziiSymptom prediction from one stool abundance valueConsumer testingweakInsufficient evidence

Dietary, supplemental, and other factors reported to shift abundance of this species. An association here does not mean that changing your level will produce the listed effect.

InterventionEffect on speciesEvidence levelStudy typeNotes
High-fiber / resistant starch diet↑ abundance in some studiesmoderateDietary intervention and observationalResponse depends on fiber type and baseline community
Mediterranean-style dietary patterns↑ associated in cohort studieslow–moderateObservationalMany confounders
Probiotics (general)Variable; F. prausnitzii is not a typical probiotic strainlowMixedMost OTC probiotics do not contain this species

What not to conclude from your test

  • That low abundance means you have IBD or will develop it
  • That a probiotic product will reliably restore F. prausnitzii
  • That your level explains symptoms without clinical context
  • That antibiotic-associated drops are permanent based on one follow-up test